摘要
SARS- CoV-2 hijacks ACE2 for cell entry. Here, the authors report that dynamic SUMOylation modulates the TOLLIP-directed selective autophagic degradation of ACE2 and suggest SUMOylation inhibition as a potential intervention against SARS-CoV-2 infection. @@@ In addition to investigating the virology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), discovering the host-virus dependencies are essential to identify and design effective antiviral therapy strategy. Here, we report that the SARS-CoV-2 entry receptor, ACE2, conjugates with small ubiquitin-like modifier 3 (SUMO3) and provide evidence indicating that prevention of ACE2 SUMOylation can block SARS-CoV-2 infection. E3 SUMO ligase PIAS4 prompts the SUMOylation and stabilization of ACE2, whereas deSUMOylation enzyme SENP3 reverses this process. Conjugation of SUMO3 with ACE2 at lysine (K) 187 hampers the K48-linked ubiquitination of ACE2, thus suppressing its subsequent cargo receptor TOLLIP-dependent autophagic degradation. TOLLIP deficiency results in the stabilization of ACE2 and elevated SARS-CoV-2 infection. In conclusion, our findings suggest selective autophagic degradation of ACE2 orchestrated by SUMOylation and ubiquitination as a potential way to combat SARS-CoV-2 infection.
学科与关键词
- P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradationLiu, Ming; Lu, Bingtai; Li, Yue; Yuan, Shuofeng; Zhuang, Zhen; Li, Guangyu; Wang, Dong; Ma, Liuheyi; Zhu, Jianheng; Zhao, Jinglu; Chan, Chris Chung-Sing; Poon, Vincent Kwok-Man; Chik, Kenn Ka-Heng; Zhao, Zhiyao; Xian, Huifang; Zhao, Jingxian; Zhao, Jincun*; Chan, Jasper Fuk-Woo*; Zhang, Yuxia*Signal Transduction and Targeted Therapy, 2023, 8(1): 385.
- Determining available strategies for prevention and therapy: Exploring COVID-19 from the perspective of ACE2 (Review)Cai, Liyang; Guo, Xi; Cao, Yuchen; Ying, Peixi; Hong, Libing; Zhang, Yuxi; Yi, Guoguo*; Fu, Min*International Journal of Molecular Medicine, 2021, 47(4): 43.被引 7
- Potential use of the S-protein-Angiotensin converting enzyme 2 binding pathway in the treatment of coronavirus disease 2019Feng, Long; Fu, Shihui; Zhang, Pei; Zhang, Yujie; Zhao, Yali*; Yao, Yao*; Luo, Leiming*; Ping, Ping*Frontiers in Public Health, 2022, 10: 1050034.
